KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Debt Ratio (2016 - 2025)

Pfizer (PFE) has disclosed Debt Ratio for 17 consecutive years, with 0.28 as the latest value for Q2 2025.

  • On a quarterly basis, Debt Ratio rose 4.85% to 0.28 in Q2 2025 year-over-year; TTM through Sep 2025 was 1.14, a 268.62% increase, with the full-year FY2024 number at 0.27, down 15.5% from a year prior.
  • Debt Ratio was 0.28 for Q2 2025 at Pfizer, up from 0.27 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.89 in Q4 2022 to a low of 0.19 in Q2 2022.
  • A 5-year average of 0.36 and a median of 0.28 in 2023 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: skyrocketed 211.7% in 2022, then crashed 68.15% in 2023.
  • Pfizer's Debt Ratio stood at 0.21 in 2021, then soared by 211.7% to 0.66 in 2022, then tumbled by 52.03% to 0.32 in 2023, then fell by 15.5% to 0.27 in 2024, then rose by 4.31% to 0.28 in 2025.
  • Per Business Quant, the three most recent readings for PFE's Debt Ratio are 0.28 (Q2 2025), 0.27 (Q4 2024), and 0.31 (Q3 2024).